Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Physiol Meas ; 35(4): 533-47, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24577344

ABSTRACT

Quantification of regional myocardial blood flow (rMBF) with first-pass magnetic resonance imaging (FP-MRI) requires two contrast agent injections (dual bolus technique), inducing error in the determined rMBF if the injections differ. We hypothesize that using input and residue curves of the same injection would be more reliable. We aim to introduce and evaluate a novel method to correct the high concentration arterial input function (AIF) for determination of rMBF. Sixteen patients with non-Hodgkin's lymphoma were examined before and after chemotherapy. The input function was solved by correcting initial high concentration AIF using the ratio of low and high contrast AIF areas, normalized by corresponding heart rates (modified dual bolus method). For comparison, the scaled low contrast AIF was used as an input function (dual bolus method). Unidirectional transfer coefficient K(trans) was calculated using both methods. K(trans)-values determined with the dual bolus (0.81 ± 0.32 ml g(-1) min(-1)) and modified dual bolus (0.77 ± 0.42 ml g(-1) min(-1)) methods were in agreement (p = 0.21). Mean K(trans)-values increased from 0.76 ± 0.43 to 0.89 ± 0.55 ml g(-1) min(-1) after chemotherapy (p = 0.17). The modified dual bolus technique agrees with the dual bolus technique (R2 = 0.899) when the low and high contrast injections are similar. However, when this is not the case, the modified dual bolus technique may be more reliable.


Subject(s)
Magnetic Resonance Imaging/methods , Myocardial Perfusion Imaging/methods , Arteries/physiology , Dose-Response Relationship, Drug , Drug Therapy , Female , Humans , Male , Middle Aged , Signal Processing, Computer-Assisted , Time Factors
2.
J Hum Hypertens ; 25(12): 746-51, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21248782

ABSTRACT

Early detection of left ventricular hypertrophy (LVH) is beneficial, since treatment-induced regression of LVH has been unequivocally associated with a better prognosis. Our aim was to study the relation of cardiac remodelling and natriuretic peptides (NPs) in stage 1 hypertension. We studied 175 (46±7 years, 87 women and 88 men) apparently healthy middle-aged that had never been treated for hypertension. Left ventricular and atrial parameters were determined by magnetic resonance imaging. Systolic blood pressure (BP) correlated with left ventricular mass index (LVMI) (r=0.23, P<0.01) and ventricular septum thickness index (IVSI) (r=0.29, P<0.001). N-terminal pro-B-type NP (NT-proBNP) or N-terminal pro-atrial NP (NT-proANP) did not correlate with BP, LVMI or IVSI. NT-proANP correlated with left atrial area index (LAAI) (r=0.38, P<0.001), and subjects with LVH had higher LAAI than subjects with normal left ventricular geometry and no LVH (11.2±0.3 vs 10.0±0.2 cm(2) m(-2), P<0.001). In conclusion, measurement of NT-proBNP or NT-proANP does not appear to discriminate LVH in middle-aged, never treated and apparently healthy hypertensives. NT-proANP, but not NT-proBNP, reflects early cardiac remodelling in hypertensive heart disease.


Subject(s)
Atrial Natriuretic Factor/blood , Hypertension/complications , Hypertrophy, Left Ventricular/epidemiology , Hypertrophy, Left Ventricular/pathology , Peptide Fragments/blood , Ventricular Remodeling/physiology , Adult , Biomarkers/blood , Case-Control Studies , Female , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Humans , Hypertension/blood , Hypertension/physiopathology , Hypertrophy, Left Ventricular/blood , Incidence , Magnetic Resonance Imaging , Male , Middle Aged , Natriuretic Peptide, Brain/blood , Severity of Illness Index
4.
Bone Marrow Transplant ; 36(12): 1077-82, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16247436

ABSTRACT

Cardiotoxicity is potentially the most threatening nonhaematological side effect of high-dose CY. We prospectively evaluated the very acute cardiac effects of high-dose CY in 17 adult non-Hodgkin's lymphoma (NHL) patients receiving CY 1500 mg/m2/day as a part of BEAC high-dose therapy (HDT). Magnetic resonance imaging (MRI) and plasma natriuretic peptide (NT-proBNP, NT-proANP) measurements were performed prior to HDT (d-7) and just after completing HDT (d-2). After the high-dose CY left atrial end-systolic area increased from 15.2+/-1.2 to 18.5+/-1.4 cm2 (P=0.001), left ventricular end-diastolic volume from 136.1+/-12.3 to 156.6+/-11.1 cm3 (P=0.04) and left ventricular end-systolic volume from 67.4+/-7.8 to 75.3+/-7.1 cm3 (P=0.018). However, no significant change in left ventricular ejection fraction (LVEF) was observed. At the same time, plasma levels of NT-proBNP increased from 134.9+/-53.3 to 547.1+/-168.4 pmol/l (P=0.003) and NT-proANP from 481.1+/-105.5 to 1056.6+/-193.1 pmol/l (P=0.001), respectively. To conclude, high-dose CY results in very acute cardiac toxicity characterised by enlargement of the heart chambers in NHL patients previously treated with anthracyclines. This toxicity can be detected with increased concentrations of circulating natriuretic peptides but not with LVEF measurement.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Heart/drug effects , Lymphoma, Non-Hodgkin/complications , Lymphoma, Non-Hodgkin/therapy , Stem Cell Transplantation/methods , Adult , Aged , Cardiovascular System/pathology , Carmustine/therapeutic use , Cyclophosphamide/therapeutic use , Cytarabine/therapeutic use , Etoposide/therapeutic use , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Natriuretic Peptides/blood , Peptides/chemistry , Prospective Studies , Time Factors , Transplantation, Autologous , Ventricular Dysfunction, Left/diagnosis , Ventricular Function, Left
5.
Q J Nucl Med Mol Imaging ; 49(1): 97-105, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15724139

ABSTRACT

The autonomic nervous system plays an important role in the regulation of cardiac function and the regional distribution of cardiac nerve terminals can be visualized using scintigraphic techniques. The most commonly used tracer is iodine-123-metaiodobenzylguanidine (MIBG) but C-11-hydroxyephedrine has also been used with PET. When imaging with MIBG, the ratio of heart-to-mediastinal counts is used as an index of tracer uptake, and regional distribution is also assessed from tomographic images. The rate of clearance of the tracer can also be measured and indicates the function of the adrenergic system. Innervation imaging has been applied in patients with susceptibility to arrhythmias, coronary artery disease, hypertrophic and dilated cardiomyopathy and anthracycline induced cardiotoxicity. Abnormal adrenergic innervation or function appear to exist in many pathophysiological conditions indicating that sympathetic neurons are very susceptible to damage. Abnormal findings in innervation imaging also appear to have significant prognostic value especially in patients with cardiomyopathy. Recently, it has also been shown that innervation imaging can monitor drug-induced changes in cardiac adrenergic activity. Although innervation imaging holds great promise for clinical use, the method has not received wider clinical acceptance. Larger randomized studies are required to confirm the value of innervation imaging in various specific indications.


Subject(s)
Autonomic Nervous System/diagnostic imaging , Cardiovascular Diseases/diagnostic imaging , Heart/diagnostic imaging , Heart/innervation , Positron-Emission Tomography/methods , Humans , Positron-Emission Tomography/trends
SELECTION OF CITATIONS
SEARCH DETAIL
...